Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Cash from Investing Activities (2011 - 2026)

Verastem (VSTM) posted quarterly Cash from Investing Activities of -$16.0 million for Q1 2026, down 1090.71% quarter-over-quarter from -$1.3 million in Q4 2025.

Analysis

Verastem (VSTM) Cash from Investing Activities (2011 - 2026) Analysis & Trends

Verastem's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$16.0 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$16.0 million; the TTM figure through Mar 2026 stood at -$17.4 million (changed N/A YoY), while the FY2025 annual figure was -$9.6 million, down 116.05% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$16.0 million, down from -$1.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $31.0 million in Q1 2024, with the low at -$70.1 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $12.7 million (2022), against an average of $5.4 million.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 19634.85% in 2022, then sank 1608.05% in 2023.
  • Verastem's Cash from Investing Activities stood at $13.0 million in 2022, then decreased by 4.52% to $12.4 million in 2023, then surged by 133.14% to $29.0 million in 2024, then plunged by 104.64% to -$1.3 million in 2025, then plunged by 1090.71% to -$16.0 million in 2026.
  • Business Quant data shows VSTM's Cash from Investing Activities at -$16.0 million in Q1 2026, -$1.3 million in Q4 2025, and $29.0 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 16.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.25 Mn
Mar 31, 2026 -16.02 Mn
Dec 31, 2025 -1.35 Mn
Jun 30, 2024 28.99 Mn
Mar 31, 2024 30.98 Mn
Dec 31, 2023 12.44 Mn
Sep 30, 2023 -70.08 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 -804,000.00
Dec 31, 2022 13.03 Mn
Sep 30, 2022 4.65 Mn
Jun 30, 2022 29.25 Mn
Mar 31, 2022 19.26 Mn
Dec 31, 2021 66,000.00
Sep 30, 2021 10.00 Mn
Jun 30, 2021 2.39 Mn
Mar 31, 2021 -12.37 Mn
Dec 31, 2020 -79.38 Mn
Sep 30, 2020 -6,000.00
Jun 30, 2020 -27,000.00